Di Bugno C, Dapporto P, Giorgi R, Manzini S, Paoli P, Subissi A, Arcamone F
Laboratori Guidotti S.p.A., San Piero a Grado (Pisa), Italy.
Chirality. 1994;6(5):382-8. doi: 10.1002/chir.530060505.
The enantiomers of 1-methyl-3-(10H-phenothiazine-10-ylmethyl)-1-azoniabicyclo[2 ,2,2]octane iodide (1) were prepared by chiral chromatographic resolution of the precursor mequitazine (2). The (+)-(S)-enantiomer 1b is 10-fold more potent than (-)-(R)-enantiomer 1a as a histamine antagonist, while the two enantiomers show the same antimuscarinic activity in vitro. The absolute configuration of the more active dextrorotatory isomer has been determined by X-ray analysis. Conformational analysis and molecular modeling suggest that the (+)-(S)-enantiomer can adopt a conformation similar to that attributed to the receptor binding conformers of classical antihistamines.
通过前体美喹他嗪(2)的手性色谱拆分制备了1-甲基-3-(10H-吩噻嗪-10-基甲基)-1-氮杂双环[2,2,2]辛烷碘化物(1)的对映体。作为组胺拮抗剂,(+)-(S)-对映体1b的效力比(-)-(R)-对映体1a强10倍,而这两种对映体在体外表现出相同的抗毒蕈碱活性。活性更强的右旋异构体的绝对构型已通过X射线分析确定。构象分析和分子模拟表明,(+)-(S)-对映体可以采用与经典抗组胺药的受体结合构象相似的构象。